◼ Archived
Business
🔮 fades ✗
Why Sionna Therapeutics Stock Is Crashing 91% to a Record Low
3 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Sionna Therapeutics
2 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Business
🔮 fades ✓
Why Vertex Pharma Popped, As A Key Rival Plummeted 90%
Vertex Pharmaceuticals shares rise as rival Sionna Therapeutics sees its stock collapse following a failed cystic fibrosis drug trial.